Sven Blobner

Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy

R. Offringa, Michael Volkmar, Susann Wendler, 2020, Nature Communications.

IgE type multiple myeloma exhibits hypermutated phenotype and tumor reactive T cells

S. Fröhling, H. Goldschmidt, K. Rippe, 2022, Journal for ImmunoTherapy of Cancer.

Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma

P. Greif, I. Jeremias, M. Niyazi, 2023, Neuro-oncology advances.

Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host disease

Clare L. Bennett, S. Henderson, V. Plagnol, 2018, JCI insight.